Cohance Lifesciences Ltd Financials Statements

    Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

    Consolidate
    Standalone
    Financial Year
    Jun '25
    Mar '25
    Dec '24
    Sep '24
    Jun '24
    Total Qtr Revenue cr
    563.48
    412.59
    322.86
    271.84
    248.85
    Other Income Qtr Cr14.1710.5715.7114.1218.16
    Operating Revenues Qtr549.31402.02307.15257.72230.69
    Loading chart...
    Operating Expenses Qtr
    437.30
    328.46
    189.45
    153.71
    150.76
    Operating Profit Qtr
    112.01
    73.56
    117.70
    104.01
    79.93
    EBITDA Qtr Cr
    118.08
    84.13
    133.41
    118.13
    98.09
    Depreciation Qtr
    45.14
    26.78
    20.35
    16.96
    13.40
    Net Profit Qtr
    48.88
    42.01
    82.88
    82.21
    60.77
    Basic EPS Qtr
    1.28
    1.65
    3.26
    3.23
    2.39
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -